Viktor Arsov,
CLINICAL CARDIOLOGY >>> Efficacy and Safety of Alirocumab as Add-on Therapy in High–Cardiovascular-Risk Patients With…
Efficacy and Safety of Alirocumab as Add‐on Therapy in High–Cardiovascular‐Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosuvastatin (10 or 20…
Overview of attention for article published in Clinical Cardiology: International Journal for Cardiovascular Diseases, September 2014
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (89th percentile)
-
High Attention Score compared to outputs of the same age and source (91st percentile)
Readers on
- mendeley
- 116 Mendeley